Skip to content
Clinical Trials – home

ALTERNARIA ALTERNATA (402): A Comprehensive Guide for Patients

0 / 2
trials open to patients / all trials
1+
Countries

In short

This article discusses clinical trials investigating the use of Alternaria Alternata (402) in allergy testing. Alternaria Alternata is a common mold allergen, and these studies aim to evaluate its effectiveness and safety in diagnosing allergies. The trials focus on patients with moderate to severe allergic rhinitis or rhinoconjunctivitis, exploring the potential of this allergen extract in skin prick tests for accurate allergy diagnosis.

At a glance

Drug Name
Alternaria Alternata (402)
Formulation
Solution for skin-prick test
Use in Trials
Diagnostic tool for allergy testing
Target Condition
Moderate to severe allergic rhinitis/rhinoconjunctivitis
Administration Route
Topical (skin prick)
Dosage
1 drop per test
Patient Age Range
18-65 years
Key Inclusion Criteria
History of allergy symptoms, positive skin prick test, specific IgE levels
Key Exclusion Criteria
Previous immunotherapy, severe asthma, immune system disorders

What is Alternaria alternata?

Alternaria alternata (402) is an active substance used in allergy testing and treatment. It is derived from a type of mold called Alternaria alternata, which is a common environmental allergen. This substance is classified as a structurally diverse substance - allergen, meaning it's a complex biological molecule capable of triggering allergic reactions in sensitive individuals.

Medical Use

The primary medical use of Alternaria alternata (402) is in the form of a solution for skin-prick tests. Skin-prick tests are a common method used by allergists to diagnose specific allergies. In this context, Alternaria alternata (402) is used to identify if a patient is allergic to this particular type of mold.

While not explicitly mentioned in the provided clinical trial data, allergen extracts like Alternaria alternata are sometimes also used in immunotherapy treatments to help desensitize patients to specific allergens over time.

Administration

The product containing Alternaria alternata (402) is administered topically, which means it's applied to the surface of the skin. Specifically, it's used in a skin-prick test, where a small amount of the allergen solution is placed on the skin, usually on the forearm or back, and the skin is then lightly pricked to allow the solution to enter the outer layer of skin.

The dosage information provided indicates that the maximum daily dose and maximum total dose is 1 drop (Gtt). This reflects the typical procedure for skin-prick tests, where only a small amount of the allergen is needed to elicit a reaction in allergic individuals.

Clinical Trials

While the provided clinical trial data doesn't focus specifically on Alternaria alternata (402), it's mentioned as an auxiliary product in trials studying other allergens. This suggests that it may be used as part of the diagnostic process in these studies, likely to identify or confirm allergies in study participants.

Potential Benefits

The main benefit of Alternaria alternata (402) in skin-prick tests is its ability to accurately diagnose allergies to this specific mold. Accurate diagnosis is crucial for several reasons:

  • It helps patients understand their triggers and avoid them when possible.
  • It guides healthcare providers in developing appropriate treatment plans.
  • It can inform decisions about whether allergen immunotherapy might be beneficial.

Precautions and Considerations

While skin-prick tests are generally safe, there are some important considerations:

  • Allergic reactions: In rare cases, patients may experience a severe allergic reaction during a skin-prick test. Therefore, these tests should always be performed under medical supervision.
  • Medication interactions: Certain medications, particularly antihistamines, can interfere with the results of skin-prick tests. Patients should inform their healthcare provider about all medications they're taking.
  • Skin conditions: Patients with certain skin conditions may not be suitable candidates for skin-prick tests.
  • Pregnancy: While not specifically mentioned for this product, allergy testing is often avoided during pregnancy unless absolutely necessary.

It's important to note that while this article provides general information about Alternaria alternata (402) and its use in allergy testing, individual experiences may vary. Always consult with a healthcare professional for personalized medical advice and before undergoing any medical tests or treatments.

Questions people often ask

Conditions where Alternaria Alternata (402) is being studied

Each condition opens its own overview and trial list

Trials with Alternaria Alternata (402)

Recruiting trials first

See all 2 →
Quick filters
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.